argenx SE (ARGX) Financials

ARGX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 5.0 billion 491.9 million
2023-09-30 ? ?
2023-06-30 3.5 billion 365.1 million
2023-03-31 ? ?

ARGX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -124.9 million ?
2023-09-30 ? ?
2023-06-30 -281.6 million ?
2023-03-31 ? ?

ARGX Net Income

No data available :(

ARGX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 3.5 billion - -
2023-09-30 2.0 billion - -
2023-06-30 2.2 billion - 12.2 million
2023-03-31 - - -

ARGX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 113.2 million
2023-09-30 61.5 million
2023-06-30 60.7 million
2023-03-31 60.6 million

ARGX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 48.0 million 551.5 million - -
2023-09-30 - 203.0 million 203.2 million -
2023-06-30 521682 212.6 million 174.9 million -
2023-03-31 - 180.8 million 162.6 million -

ARGX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 815.5 million 201.7 million
2023-09-30 349.1 million 38.1 million
2023-06-30 294.2 million 26.1 million
2023-03-31 238.9 million 20.0 million

ARGX

Price: $388.20

52 week price:
327.73
550.76

Earnings Per Share: -5.14 USD

P/E Ratio: -95.08

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 205974

Ebitda: -24.6 million

Market Capitalization: 22.9 billion

Links: